featured
Low–Molecular Weight Heparin for Pancreatic Cancer Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial
J. Clin. Oncol 2015 May 18;[EPub Ahead of Print], U Pelzer, B Opitz, G Deutschinoff, M Stauch, PC Reitzig, S Hahnfeld, L Müller, M Grunewald, JM Stieler, M Sinn, T Denecke, S Bischoff, H Oettle, B Dörken, H RiessFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.